About Pivot Bio
Pivot Bio is a company based in Berkeley (United States) founded in 2010 by Alvin Tamsir and Karsten Temme.. Pivot Bio has raised $618.08 million across 7 funding rounds from investors including Monsanto, Bunge and Rockefeller Capital Management. Pivot Bio offers products and services including PROVEN® 40, RETURN®, and N-OVATOR Program. Pivot Bio operates in a competitive market with competitors including Amyris, Inscripta, Ginkgo Bioworks, Syngenta and Asimov, among others.
- Headquarter Berkeley, United States
- Founders Alvin Tamsir, Karsten Temme
- Stage Unicorn
-
Sectors
HealthcareAgriculture Chemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$618.08 M (USD)
in 7 rounds
-
Latest Funding Round
$430 M (USD), Series D
Jul 19, 2021
-
Investors
Monsanto
& 17 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pivot Bio
Pivot Bio offers a comprehensive portfolio of products and services, including PROVEN® 40, RETURN®, and N-OVATOR Program. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers steady nutrition for corn crops to enhance yield.
Boosts nutrition for wheat and small grains productivity.
Rewards farmers for using microbial nitrogen to cut emissions.
Unlock access to complete
Unlock access to complete
Software Development Team
21 people
Leadership Team
20 people
Scientific Team
10 people
Product Management Team
10 people
Sales and Marketing
7 people
Data Analysis and Operations Team
6 people
Operations Team
6 people
Finance and Accounting
3 people
Unlock access to complete
Funding Insights of Pivot Bio
Pivot Bio has successfully raised a total of $618.08M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $430 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series D — $430.0M
-
First Round
First Round
(30 Oct 2014)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series D - Pivot Bio | Valuation | DCVC , Temasek | |
| May, 2020 | Amount | Series C - Pivot Bio | Valuation | Temasek , Breakthrough Energy | |
| Oct, 2018 | Amount | Series B - Pivot Bio | Valuation | Breakthrough Energy |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pivot Bio
Pivot Bio has secured backing from 18 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Monsanto, Bunge and Rockefeller Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on sustainable investments
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pivot Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pivot Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pivot Bio Comparisons
Competitors of Pivot Bio
Pivot Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Ginkgo Bioworks, Syngenta and Asimov, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Provider of integrated suite for advanced genetic design and manufacturing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pivot Bio
Frequently Asked Questions about Pivot Bio
When was Pivot Bio founded?
Pivot Bio was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Where is Pivot Bio located?
Pivot Bio is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Who is the current CEO of Pivot Bio?
Chris Abbott is the current CEO of Pivot Bio.
Is Pivot Bio a funded company?
Pivot Bio is a funded company, having raised a total of $618.08M across 7 funding rounds to date. The company's 1st funding round was a Series B of $71.33M, raised on Oct 30, 2014.
What does Pivot Bio do?
Pivot Bio was founded in 2010 and is headquartered in Berkeley, United States. Microbe-based products for crop nutrition are developed within the agricultural biotechnology sector. Nitrogen-fixing microorganisms are engineered to establish symbiotic relationships with corn plants, converting atmospheric nitrogen into usable forms directly at the roots through biological processes. Application occurs via an in-furrow method, with consistent performance across varying topography, weather conditions, and soil types.
Who are the top competitors of Pivot Bio?
What products or services does Pivot Bio offer?
Pivot Bio offers PROVEN® 40, RETURN®, and N-OVATOR Program.
Who are Pivot Bio's investors?
Pivot Bio has 18 investors. Key investors include Monsanto, Bunge, Rockefeller Capital Management, Temasek, and DCVC.
What is Pivot Bio's valuation?
The valuation of Pivot Bio is $2B as of Jul 2021.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.